Retinoic acid-induced protein 3: Identification and characterisation of a novel prognostic colon cancer biomarker

RAI3 is a putative prognostic marker that identifies a small subset of CC patients with high recurrence risk. This study demonstrates the potential value of modern proteomic technology in clinically relevant applications.